Modèles transgéniques pour l'étude de la fonction ... - Epublications

(AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol
Chem 274, 18470-6.
Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y., Jan, Y. N., Cabrera, C.
V., Buskin, J. N., Hauschka, S. D., Lassar, A. B. et al. (1989). Interactions between
heterologous helix-loop-helix proteins generate complexes that bind specifically to a common
DNA sequence. Cell 58, 537-44.
Nadler, M. J., McLean, P. A., Neel, B. G. and Wortis, H. H. (1997). B cell antigen
receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines. J Immunol 159, 4233-
43.
Nambu, Y., Sugai, M., Gonda, H., Lee, C. G., Katakai, T., Agata, Y., Yokota, Y. and
Shimizu, A. (2003). Transcription-coupled events associating with immunoglobulin switch
region chromatin. Science 302, 2137-40.
Niiro, H. and Clark, E. A. (2002). Regulation of B-cell fate by antigen-receptor signals.
Nat Rev Immunol 2, 945-56.
Nimmerjahn, F. and Ravetch, J. V. (2005). Divergent immunoglobulin g subclass
activity through selective Fc receptor binding. Science 310, 1510-2.
Nishimura, T., Nakatake, Y., Konishi, M. and Itoh, N. (2000). Identification of a novel
FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492, 203-6.
Nitschke, L. (2005). The role of CD22 and other inhibitory co-receptors in B-cell
activation. Curr Opin Immunol 17, 290-7.
Nitschke, L., Carsetti, R., Ocker, B., Kohler, G. and Lamers, M. C. (1997). CD22 is a
negative regulator of B-cell receptor signalling. Curr Biol 7, 133-43.
Nitschke, L., Kestler, J., Tallone, T., Pelkonen, S. and Pelkonen, J. (2001). Deletion of
the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ
recombination and altered D gene usage. J Immunol 166, 2540-52.
Niwa, R., Natsume, A., Uehara, A., Wakitani, M., Iida, S., Uchida, K., Satoh, M. and
Shitara, K. (2005). IgG subclass-independent improvement of antibody-dependent cellular
cytotoxicity by fucose removal from Asn297-linked oligosaccharides. J Immunol Methods 306,
151-60.
Noble, P. W., Lake, F. R., Henson, P. M. and Riches, D. W. (1993). Hyaluronate
activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factoralpha-dependent
mechanism in murine macrophages. J Clin Invest 91, 2368-77.
Norvell, A., Mandik, L. and Monroe, J. G. (1995). Engagement of the antigen-receptor
on immature murine B lymphocytes results in death by apoptosis. J Immunol 154, 4404-13.
Novobrantseva, T. I., Martin, V. M., Pelanda, R., Muller, W., Rajewsky, K. and
Ehlich, A. (1999). Rearrangement and expression of immunoglobulin light chain genes can
precede heavy chain expression during normal B cell development in mice. J Exp Med 189, 75-
88.
Nusse, R. and Varmus, H. E. (1982). Many tumors induced by the mouse mammary
tumor virus contain a provirus integrated in the same region of the host genome. Cell 31, 99-109.
Nutt, S. L. and Kee, B. L. (2007). The transcriptional regulation of B cell lineage
commitment. Immunity 26, 715-25.
O'Keefe, T. L., Williams, G. T., Batista, F. D. and Neuberger, M. S. (1999).
Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to
development of high affinity autoantibodies. J Exp Med 189, 1307-13.
O'Keefe, T. L., Williams, G. T., Davies, S. L. and Neuberger, M. S. (1996).
Hyperresponsive B cells in CD22-deficient mice. Science 274, 798-801.
Obara, N. and Lesot, H. (2004). Subcellular localization of beta-catenin and cadherin
expression in the cap-stage enamel organ of the mouse molar. Histochem Cell Biol 121, 351-8.
168